239 related articles for article (PubMed ID: 12068842)
21. Role of androgens, progestins and tibolone in the treatment of menopausal symptoms: a review of the clinical evidence.
Garefalakis M; Hickey M
Clin Interv Aging; 2008; 3(1):1-8. PubMed ID: 18488873
[TBL] [Abstract][Full Text] [Related]
22. An evidence-based approach to hormonal therapies for premenopausal women with fibroids.
Lethaby AE; Vollenhoven BJ
Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):307-31. PubMed ID: 17905660
[TBL] [Abstract][Full Text] [Related]
23. Clinical effects of tibolone in postmenopausal women after 5 years of tamoxifen therapy for breast cancer.
Dimitrakakis C; Keramopoulos D; Vourli G; Gaki V; Bredakis N; Keramopoulos A
Climacteric; 2005 Dec; 8(4):342-51. PubMed ID: 16390769
[TBL] [Abstract][Full Text] [Related]
24. Tibolone: the way to beat many a postmenopausal ailments.
Lazovic G; Radivojevic U; Marinkovic J
Expert Opin Pharmacother; 2008 Apr; 9(6):1039-47. PubMed ID: 18377345
[TBL] [Abstract][Full Text] [Related]
25. Preferential prescribing of tibolone and combined estrogen plus progestogen therapy in postmenopausal women.
Velthuis-Te Wierik EJ; Hendricks PT; Martinez C
Menopause; 2007; 14(3 Pt 1):518-27. PubMed ID: 17224856
[TBL] [Abstract][Full Text] [Related]
26. Cardiovascular effects of tibolone: a selective tissue estrogenic activity regulator.
Campisi R; Marengo FD
Cardiovasc Drug Rev; 2007; 25(2):132-45. PubMed ID: 17614936
[TBL] [Abstract][Full Text] [Related]
27. Rationale for low-dose systemic hormone replacement therapy and review of estradiol 0.5 mg/NETA 0.1 mg.
Johansen OE; Qvigstad E
Adv Ther; 2008 Jun; 25(6):525-51. PubMed ID: 18568306
[TBL] [Abstract][Full Text] [Related]
28. Options for hormone therapy in women who have had a hysterectomy.
Haney AF; Wild RA
Menopause; 2007; 14(3 Pt 2):592-7; quiz 598-9. PubMed ID: 17476150
[TBL] [Abstract][Full Text] [Related]
29. Tibolone and low-dose continuous combined hormone treatment: vaginal bleeding pattern, efficacy and tolerability.
Hammar ML; van de Weijer P; Franke HR; Pornel B; von Mauw EM; Nijland EA;
BJOG; 2007 Dec; 114(12):1522-9. PubMed ID: 17995496
[TBL] [Abstract][Full Text] [Related]
30. The effects of tibolone and oestrogen-based HT on breast cell proliferation and mammographic density.
von Schoultz B
Maturitas; 2004 Sep; 49(1):S16-21. PubMed ID: 15351103
[TBL] [Abstract][Full Text] [Related]
31. Different effects of tibolone and continuous combined estrogen plus progestogen hormone therapy on sex hormone binding globulin and free testosterone levels--an association with mammographic density.
Hofling M; Carlström K; Svane G; Azavedo E; Kloosterboer H; Von Schoultz B
Gynecol Endocrinol; 2005 Feb; 20(2):110-5. PubMed ID: 15823831
[TBL] [Abstract][Full Text] [Related]
32. The need for tissue selective menopausal agents.
Eden J
Gynecol Endocrinol; 2005 Jul; 21 Suppl 1():22-7. PubMed ID: 16112952
[TBL] [Abstract][Full Text] [Related]
33. Sexual dysfunction in the peri- and postmenopause. Status of incidence, pharmacological treatment and possible risks. A secondary publication.
Gregersen N; Jensen PT; Giraldi AE
Dan Med Bull; 2006 Aug; 53(3):349-53. PubMed ID: 17092454
[TBL] [Abstract][Full Text] [Related]
34. Future research--potentially rewarding areas for investigation.
Wiseman RA
Postgrad Med J; 1978; 54 Suppl 2():95-9. PubMed ID: 740588
[TBL] [Abstract][Full Text] [Related]
35. Tibolone: cancers of the breast and endometrium.
Prescrire Int; 2006 Jun; 15(83):107. PubMed ID: 16764100
[TBL] [Abstract][Full Text] [Related]
36. Current trends in hormone replacement therapy.
Khashoggi TY
Saudi Med J; 2002 May; 23(5):495-502. PubMed ID: 12070567
[TBL] [Abstract][Full Text] [Related]
37. Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women.
Nugent AG; Leung KC; Sullivan D; Reutens AT; Ho KK
Clin Endocrinol (Oxf); 2003 Dec; 59(6):690-8. PubMed ID: 14974909
[TBL] [Abstract][Full Text] [Related]
38. Benefits and risks of long-term low-dose oral continuous combined hormone therapy.
van de Weijer PH; Mattsson LA; Ylikorkala O
Maturitas; 2007 Mar; 56(3):231-48. PubMed ID: 17034966
[TBL] [Abstract][Full Text] [Related]
39. Tibolone: a review.
Albertazzi P; Di Micco R; Zanardi E
Maturitas; 1998 Nov; 30(3):295-305. PubMed ID: 9881330
[TBL] [Abstract][Full Text] [Related]
40. Development and present state of hormone replacement therapy.
Kopera H; van Keep PA
Int J Clin Pharmacol Ther Toxicol; 1991 Oct; 29(10):412-7. PubMed ID: 1748541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
